Себестоимость Изменить Дата
Abbott USD 5.3B 380M 2026-03
Bayer EUR 5.23B 731M 2026-03
Bio-Rad Laboratories USD 348M 38.4M 2025-12
EDAP TMS EUR 7.91M 1.31M 2025-09
J&J USD 8.07B 103M 2026-03
Mesa Laboratories USD 21.92M 1.78M 2024-09
OraSure Technologies USD 15.43M 113K 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Siemens EUR 12.07B 565M 2026-03
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Tosoh JPY 193.73B 3.46B 2026-03
Trinity Biotech USD 7.84M 3.14M 2025-09
Veracyte USD 38.49M 794K 2026-03